期刊文献+

抗真菌药 醋酸卡泊芬净(caspofungin acetate) 被引量:2

下载PDF
导出
摘要 1商品名 Cancidas 2开发与上市厂商 默克公司开发,2001年首次在美国上市. 3适应证 本品适用于食管念珠菌病,以及其它药物(如两性霉素B、两性霉素B脂质体、伊曲康唑等)治疗无效或不耐受的侵入性曲霉病.
出处 《世界临床药物》 CAS 2004年第6期381-382,共2页 World Clinical Drug
  • 相关文献

同被引文献23

  • 1张凡(编译),王强(审校).卡泊芬净醋酸酯[J].临床药物治疗杂志,2006,4(1):39-44. 被引量:3
  • 2Makhoul IR, Kassis I, Smolkin T, et al. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics,2001,107 (1) :61.
  • 3Anon. Products: Vfend tablets angd infusion. Parmaceutical,2002,269 (7214) :317.
  • 4Anon. News :Broad - spactrum antifungal for invasive aspergillosis launched. Parmaceutical. 2002, 269(7214) :311.
  • 5Yuet W. Voriconazole versus amphotericin for primary therapy of invasive aspergillosis. N Engl J Med,2002,347(6) :408.
  • 6V enkataramanan R, Zang S, Gayowski T, et al. V oriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother, 2002, 46(9) :3091.
  • 7Romero A J, Pogamp P L, Nilsson LG, et al. Effect of Voriconazole on the pharmacokinetics of cycrosporine in renal transplant patients. J Clin Pharmacol Ther, 2002,71 (4) :226.
  • 8Denning DW. Echinocandin antifungal drugs. Lancet, 2003,362 (12) :1142.
  • 9Balani SK, Xu X, Arison Bh, et al. Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.Drug Metab Dispos, 2000, 28 (10): 1274.
  • 10Villanueva A, Arathoon EG, Gotuzzo E, et al. A randomized double - blind study of caspofung in versus amphoteric in for the treatment of candidal esophagitis. Clin Infect Dis, 2001, 33 (12) :1529.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部